Merja Haikola
Comptroller/Controller/Auditor at BBS-BIOACTIVE BONE SUBSTITUTES OYJ
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pekka Kalevi Jalovaara | M | 83 | 21 years | |
| Jarmo Olavi Halonen | M | 72 | 8 years | |
| Jari Kortesluoma | M | - | 2 years | |
| Seppo Antero Nevalainen | M | - | 4 years | |
| Mikko Viitanen | M | - | 18 years | |
| Juliusz Rakowski | M | - | 1 years | |
| Kimmo Tyni | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hannu Olavi Säynäjäkangas | M | 70 | 9 years | |
| Tomi Juhani Numminen | M | 53 |
AKELA Pharma Oy
 AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | 9 years |
| Hanna Tölli | M | 41 | - | |
| Ilkka Kangasniemi | M | - | 4 years | |
| Taneli Jouhikainen | M | 57 |
AKELA Pharma Oy
AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | 3 years |
| Auvo Antero Juhani Kaikkonen | M | 64 | - | |
| Timo Törmälä | M | - |
Cancer Targeting Technologies Oy
 Cancer Targeting Technologies Oy Pharmaceuticals: MajorHealth Technology Cancer Targeting Technologies Oy used to develop anticancer drugs and drug delivery systems based on cancer specific peptides and peptide liposomes. It was also developed diagnostic tools. The company was located in Helsinki, Finland | - |
| Jari-Matti Mehto | M | - |
Cancer Targeting Technologies Oy
Cancer Targeting Technologies Oy Pharmaceuticals: MajorHealth Technology Cancer Targeting Technologies Oy used to develop anticancer drugs and drug delivery systems based on cancer specific peptides and peptide liposomes. It was also developed diagnostic tools. The company was located in Helsinki, Finland | 2 years |
| Kenneth Sandstöm | M | - | - | |
| Juha-Pekka Nuutinen | M | - | - | |
| Päivi Ylä-Kolu | F | 58 | 3 years | |
| Paul Watkins | M | - | - | |
| Soile Hakala | F | - | 3 years | |
| Liisa Hukka | F | - | 1 years | |
| Jussi Jukka | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Finland | 22 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Merja Haikola
- Personal Network
